Leukemia drug breakthrough: study tests tapering strategy to free patients from daily pills
NCT ID NCT05753384
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether people with chronic myeloid leukemia (CML) can stop taking their daily targeted therapy (TKI) without the cancer coming back. It compares two approaches: stopping the drug suddenly after a year of normal dosing, versus slowly reducing the dose over a year before stopping. The goal is to see which method helps more patients stay in remission without needing medication, while also reducing side effects and improving quality of life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC MYELOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CH Brive la Gaillarde
Brive-la-Gaillarde, France
-
CH Versailles
Versailles, France
-
CHI Creteil
Créteil, France
-
CHU Limoges
Limoges, France
-
Centre Léon Bérard
Lyon, France
-
Ch Annecy
Annecy, France
-
Ch Bayonne
Bayonne, France
-
Ch Chambery
Chambéry, France
-
Ch La Rochelle
La Rochelle, France
-
Ch Mont de Marsan
Mont-de-Marsan, France
-
Ch Perigueux
Périgueux, France
-
Chu Angers
Angers, France
-
Chu Brest
Brest, France
-
Chu Lille
Lille, France
-
Chu Nancy
Nancy, France
-
Chu Nantes
Nantes, France
-
Chu Poitiers
Poitiers, France
-
Chu Tours
Tours, France
-
Hopital Prive Du Confluent
Nantes, France
-
Oncopole Toulouse
Toulouse, France